Engineered etoposide-prednisolone co-nanocrystals for synergistic antitumor efficacy enhancement
Year: 2026
Type: article
Abstract: when endothelial cells were incubated with the co-NCs as opposed to the mono-NCs. These results open the way for the preparation of stable co-formulations and better-tolerated combined therapies.
Source: Nanoscale Advances
DOI: 10.1039/d5na00941c
Institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Unité de Technologies Chimiques et Biologiques pour la Santé, Stanford University, Czech Academy of Sciences, Czech Academy of Sciences, Institute of Macromolecular Chemistry, Cornell University, Weill Cornell Medicine
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,962
Funder: Fondation Maladies Rares
Awards: G1459320347, G2715890488, G7035538696
OpenAlex ID: W7166804395
